🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Vanessa L. Merker

Harvard University

ORCID: 0000-0002-4542-5227

Also affiliated with Massachusetts General Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation”.

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation

Genetics in Medicine(2022)10.1016/j.gim.2022.05.007

N/A

0.846DataRank · unranked

281 citations

Ludwine Messiaen, Eric Legius, Patrice Pancza, Robert A. Avery, Jaishri O. Blakeley +79 more

Integrating Tobacco Treatment Into Lung Cancer Screening

JAMA Internal Medicine(2025)10.1001/jamainternmed.2024.8399

N/A

0.416DataRank · unranked

15 citations

Jennifer S. Haas, Nancy A. Rigotti, Jordan M. Neil, Caylin J. Marotta, Amy J. Wint +9 more

Views on the impact of the COVID‐19 pandemic on health in people with Down syndrome from diverse backgrounds

American Journal of Medical Genetics Part A(2023)10.1002/ajmg.a.63233

N/A

0.345DataRank · unranked

9 citations

Sandra Baker, Jasmine M. Blake, Maria J. Cabrera, Kelli Caughman, Jeanhee Chung +19 more

Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey

Clinical Trials(2023)10.1177/17407745231209224

N/A

0.312DataRank · unranked

7 citations

Nour Al Ghriwati, Melissa Baker, Staci Martin, Daniel Berg, Gregg Erickson +8 more

Advancing neurofibromatosis and schwannomatosis clinical trial design: Consensus recommendations from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration

Clinical Trials(2023)10.1177/17407745231201345

N/A

0.165DataRank · unranked

2 citations

Andrea M. Gross, Brigitte C. Widemann, Scott R. Plotkin, Vanessa L. Merker

Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials

Clinical Trials(2023)10.1177/17407745231205577

N/A

0DataRank · unranked

5 citations

Heather L. Thompson, Pamela L. Wolters, Frank D. Buono, Cynthia M. Hingtgen, Tena Rosser +10 more

Awareness and Agreement with Neurofibromatosis Care Guidelines among Neurofibromatosis Specialists

medRxiv(2021)10.1101/2021.06.16.21259047

N/A

0DataRank · unranked

0 citations

Pamela Knight, Heather B. Radtke, Kaleb Yohay, Nicole J. Ullrich, Scott R. Plotkin +2 more

Indicators of health in Down syndrome: A virtual focus group study with patients and their parents

Journal of Applied Research in Intellectual Disabilities(2023)10.1111/jar.13065

N/A

0DataRank · unranked

22 citations

Maria J. Cabrera, Kelsey Haugen, Kavita Krell, Vanessa L. Merker, Stephanie L. Santoro

Impact of the coronavirus pandemic on mental health and health care in adults with neurofibromatosis: Patient perspectives from an online survey

American Journal of Medical Genetics Part A(2021)10.1002/ajmg.a.62490

N/A

0DataRank · unranked

10 citations

Stephanie Reda, Staci Martin, Nour Al Ghriwati, Melissa Baker, Daniel Berg +10 more